TipRanks
Advertisement
Advertisement
Apotex Health Corp.: Buy Rating Reiterated as Strong Q1 FY2027 Results Support Unchanged $40 Price Target
PremiumRatingsApotex Health Corp.: Buy Rating Reiterated as Strong Q1 FY2027 Results Support Unchanged $40 Price Target
1M ago
Apotex Q1 2027 Results Show Strong Canadian Growth and Post-IPO Deleveraging
Premium
Company Announcements
Apotex Q1 2027 Results Show Strong Canadian Growth and Post-IPO Deleveraging
1M ago
Apotex Health initiated with a Buy at Canaccord
Premium
The Fly
Apotex Health initiated with a Buy at Canaccord
2M ago
Apotex Health initiated with an Outperform at ATB Cormark
PremiumThe FlyApotex Health initiated with an Outperform at ATB Cormark
3M ago
Apotex Health initiated with a Buy at Desjardins
Premium
The Fly
Apotex Health initiated with a Buy at Desjardins
3M ago
Apotex Health initiated with a Buy at TD Cowen
Premium
The Fly
Apotex Health initiated with a Buy at TD Cowen
3M ago
Apotex Health initiated with an Outperform at BMO Capital
PremiumThe FlyApotex Health initiated with an Outperform at BMO Capital
3M ago
Premium
Ratings
Apotex Health Corp.: Buy Rating Backed by Leading Generic Position, Specialty Shift, and Post-IPO Balance Sheet Strength
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―